Covid-19 Vaccinations at Super Speciality Hospital as India Plans to Innoculate 300 Million by July

A health worker records details in the Covid-19 vaccination room at the Super Speciality Hospital Hospital in Srinagar, India, on Friday, Jan. 29, 2021. India's domestic vaccine program administers one of two shots: the AstraZeneca Plc vaccine, manufactured by the Serum Institute of India Ltd., or the Covaxin shot developed by Bharat Biotech International Ltd., a private company based in Hyderabad. Photographer: Sumit Dayal/Bloomberg via Getty Images
A health worker records details in the Covid-19 vaccination room at the Super Speciality Hospital Hospital in Srinagar, India, on Friday, Jan. 29, 2021. India's domestic vaccine program administers one of two shots: the AstraZeneca Plc vaccine, manufactured by the Serum Institute of India Ltd., or the Covaxin shot developed by Bharat Biotech International Ltd., a private company based in Hyderabad. Photographer: Sumit Dayal/Bloomberg via Getty Images
Covid-19 Vaccinations at Super Speciality Hospital as India Plans to Innoculate 300 Million by July
COMPRAR LICENCIA
¿Cómo puedo usar esta imagen?
AR$ 329.200,00
ARS

DETALLES

Restricciones:
Póngase en contacto con su oficina local para conocer todos los usos con fines comerciales o promocionales.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Crédito:
Bloomberg / Colaborador
Editorial n.º:
1230850530
Colección:
Bloomberg
Fecha de creación:
29 de enero de 2021
Fecha de subida:
Tipo de licencia:
Inf. de autorización:
No se cuenta con autorizaciones. Más información
Fuente:
Bloomberg
Nombre del objeto:
INDIA VACCINE
Tamaño máx. archivo:
4000 x 2667 px (33,87 x 22,58 cm) - 300 dpi - 4 MB